The U.S. Food and Drug Administration approved Eisai and Biogen’s application for IV maintenance dosing of lecanemab on January 27. Previously, the label called for biweekly IV dosing. The new ...

The Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the monthly intravenous (IV) maintenance regimen of ... and its open-label extension phase ...

When a jury issued a $462 million judgment against Wabash National Corp. last fall, many fleet maintenance managers were ...

Republican voter registrations in North Carolina are within one-half of 1% of Democrats for the first time this century, ...

Epson, ASEAN’s leading brand for desktop color label printers, has announced the launch of the ColorWorks CW-C8050, its newest ColorWorks on-demand color ...

Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...

Laboratory tests can monitor for renal toxicity and coagulation abnormalities, including acute severe low platelet counts, which have been observed after administration of some ASOs. Biogen licensed ...

Biogen BIIB announced that the FDA and EMA have accepted its regulatory filings seeking label expansion for a higher dose of its blockbuster spinal muscular atrophy (SMA) drug Spinraza. This new ...

WP MP Gerald Giam raised concerns about the Maintenance of Racial Harmony Bill’s broad ministerial discretion to label speech as racially inflammatory and issue restraining orders. While Minister K ...

The card, which has been compared to a nutrition label for algorithms ... bias mitigation approaches and any ongoing maintenance. The model card can also be used for some predictive algorithms ...